Rythmol and Metoclopramide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rythmol (propafenone hydrochloride) and Metoclopramide (metoclopramide hydrochloride). Common drug interactions include anaemia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Rythmol and Metoclopramide. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Rythmol?

Rythmol has active ingredients of propafenone hydrochloride. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 3,638 Rythmol users. Check the latest studies of Rythmol.

What is Metoclopramide?

Metoclopramide has active ingredients of metoclopramide hydrochloride. It is often used in nausea. eHealthMe is studying from 81,263 Metoclopramide users. Check the latest studies of Metoclopramide.

On Jul, 11, 2026

23 people who take Rythmol and Metoclopramide together, and have interactions are studied.

Rythmol and Metoclopramide drug interactions.

What are the common drug interactions of Rythmol and Metoclopramide, by gender? *:

female:

Anaemia (lack of blood)
Blood glucose decreased
Dysphagia (a condition in which swallowing is difficult or painful)
Alopecia (absence of hair from areas of the body)
Blood bilirubin increased
Blood urine present
Disease recurrence
Dry eye (lack of adequate tears)
Dysgeusia (disorder of the sense of taste)
Dysuria (painful or difficult urination)

male:

Drug ineffective
Hypotension (abnormally low blood pressure)
Chronic kidney disease
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal failure (kidney dysfunction)
Renal failure acute (rapid kidney dysfunction)

What are the common drug interactions of Rythmol and Metoclopramide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Asthenia (weakness)
Blood alkaline phosphatase increased
Blood glucose increased
Blood thyroid stimulating hormone decreased
Chest discomfort
Chest pain
Fluid overload (too much fluid in the blood)
Hypotension (abnormally low blood pressure)
Abdominal pain
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)

60+:

Anaemia (lack of blood)
Asthenia (weakness)
Dysuria (painful or difficult urination)
Eye irritation
Eye pain
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hypophagia (reduced food intake)
Leukopenia (less number of white blood cells in blood)
Photophobia (extreme sensitivity to light)

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 13.04%
Malignant Respiratory Tract Neoplasm (cancer tumour of respiratory tract): 2 people, 8.70%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 2 people, 8.70%
Arrhythmias (irregular heartbeat): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Rythmol and Metoclopramide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously